News & Activities

As a young company, Amferia is growing fast and establishing ground both in Sweden and Internationally. To keep updated on our progress and activities, do check on the below posts and don’t hesitate to contact us if you would like to know more.

News & Activities

Amferia establishes R&D operations at AstraZeneca’s BioVentureHub

October 28, 2019

 

Amferia is very excited to move into the BioVentureHub, given the strong benefits of operating in a flourishing environment with state-of-the-art infrastructure dedicated to medtech and life science companies. We are also eager to be around so many experts within life science ranging from established to early-stage companies researching in biopharmaceuticals, medical devices and diagnostics. Amferia looks forward to be part of, learn and grow in this supportive and exciting community. Read press release here: Amferia AZ Press Release

Amferia Participates in the Annual Veterinary Hygiene Conference 2019

October 24, 2019




Our CEO, Anand Kumar Rajasekharan and Product Engineer, Edvin Blomstrand had the pleasure to recently attend the annual Veterinary Hygiene Conference in Knivsta, Stockholm. One of the primary questions of this conference was about handling antibiotic resistant infections in animal wound care – a fast growing problem in Sweden and Globally. Many interesting & enlightening discussions with expert veterinary clinicians taught us a lot about the needs and challenges in animal wound care and how Amferia might expand its innovative solutions to help veterinary healthcare. Thanks for a great conference VVHF.

Amferia wins the Start-up of the Year award at Venture Cup Sweden 2019!

The Jury's Motivation for Amferia!

“With its disruptive solution, the team has the opportunity to shake several industries as they tackle one of humanity’s greatest global threats. By addressing a world problem, millions of lives will be saved. By changing the behavior of the consumer, there is also the potential to reform the market.”

“Med sin disruptiva lösning har teamet en möjlighet att skaka om flera branscher när de tacklar ett av mänsklighetens största globala hot. Genom att angripa ett världsproblem kommer miljontals liv att kunna räddas. Genom att förändra beteende hos konsumenten finns det även potential till att reformera marknaden.”

Amferia receives the prestigious EU SME Instrument (Phase 1) Grant from the European Union

Aug 1, 2019

Amferia recieves the highly competitive and coveted EU SME Instrument Phase 1 grant of 50k Euros along with the valuable business coaching to take forward our technology into the market. 

Amferia at Brilliant Minds 2019, Stockholm

June 15, 2019

Amferia was honored to pitch as one of the ‘Next Brilliant in Tech‘ at Brilliant Minds 2019 held at Stockholm between 13-15 June. With esteemed guests like President Barack Obama, Secretary John Kerry, Greta Thunberg, the conference was a enlighetening and inspiring event with much hope for the future.

Our CEO, Anand  conferred a PhD  in Materials Science  

May 18, 2019. 

Chalmers Doktorspromotion 2019

Anand was also invited to speak at the ceremony about how a research study opened pathways to entrepreneurship and to the birth of Amferia. Thank you Chalmers for the wonderful oppurtunity! 

Amferia is ‘Student Superstart’!

 – Venture Cup Väst 2019 

May 21, 2019

Once again Amferiashows up among the winners! We are so proud to be one of the winners of region west Venture Cup 2019. Such a fantastic event filled with inspiration and excitement.

The Recent UN Report on Antibiotic Resistance

May 3, 2019

The United Nations appointed Interagency Coordination Group on Antimicrobial Resistance (IACG) has presented its report on Recommendations to Combat Antimicrobial Resistance (AMR). It is clear from the report that AMR is a global and complex threat that needs to be addressed with extreme urgency and with care. Consistent, coordinated and conscious actions are demanded, especially from the World Goverments, Academia, Public, Healthcare-Industry and  Agriculture. A world where bacterial infections cannot be fought efficiently is a world of perils.

Here is an excerpt from the IACG report.

“The challenges of antimicrobial resistance are complex and multifaceted, but they are not insurmountable. Implementation of the recommendations in this report will help to save millions of lives, preserve antimicrobials for generations to come and secure the future from drug-resistant diseases.

But there is no time to wait.” 

-IACG Report, April 29, 2019

Do take a minute and read the summary of this important report Englishpdf, 653kb

Amferia presenting at the European Wound Management Conference (EWMA) 2019

In June, Anand will give a presentation about Amferia’s technology at the EWMA conference this year. Please let us know if you would like to meet and discuss more at the congress. Anand’s talk is on 5th June within the Antimicrobial session.

Amferia on Låt Oss Prata – Juan Navas, Swedbank                 May 3, 2019

Our CEO, Anand had a chat with Juan Navas from Swedbank on Swedbank’s official podcast, Låt Oss Prata (Let’s Talk). Anand and Juan discuss Amferia’s recent experience on winning the Swedbank Rivstart Entrepreneur competition.

Amferia featured in Göteborgs-Posten

February 8, 2019

Read on to know more

Amferia wins the Swedbank Rivstart 2018

February 7, 2019

Amferia is proud to become the winners of the annual entrepreneur competition hosted by Swedbank, Rivstart. From over 1825 applications, Amferia finished on top!

Amferia wins the Venture Day 2018, hosted by Chalmers Ventures

November 28, 2018

Amferia is proud to be named winners of the annual Pitch competition hosted by Chalmers Ventures.